Bonraybio Co., Ltd. (TPE:6955)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
164.00
0.00 (0.00%)
At close: Apr 28, 2026
32.35%
Market Cap 4.14B
Revenue (ttm) 306.31M
Net Income (ttm) 102.51M
Shares Out 24.80M
EPS (ttm) 4.12
PE Ratio 40.53
Forward PE n/a
Dividend 1.50 (0.91%)
Ex-Dividend Date Mar 19, 2026
Volume 28,000
Average Volume 11,921
Open 163.00
Previous Close 164.00
Day's Range 158.50 - 166.00
52-Week Range 123.91 - 186.96
Beta 0.18
RSI 53.62
Earnings Date May 13, 2026

About Bonraybio

Bonraybio Co., Ltd., a development stage company, manufactures medical instruments and solutions for the male infertility market. The company provides LensHooke X12 PRO semen analysis systems; and LensHooke X1 PRO semen quality analyzers. It also provides consumables, such as CS3 semen test slides; CA0/CA1 sperm separation solutions; and CS1 semen test cassettes. In addition, the company provides X QC Reticles, X QC video tools, and X QC beads; sperm DNA fragmentation test kits; and S10 data consolidation software. Bonraybio Co., Ltd. was found... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2015
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 6955
Full Company Profile

Financial Performance

In 2025, Bonraybio's revenue was 306.31 million, an increase of 37.43% compared to the previous year's 222.88 million. Earnings were 102.51 million, an increase of 49.94%.

Financial Statements

News

There is no news available yet.